100 related articles for article (PubMed ID: 1378347)
21. Multiphasic morphine modulation of substance P release from capsaicin-sensitive primary afferent fibers.
Cano G; Arcaya JL; Gómez G; Maixner W; Suarez-Roca H
Neurochem Res; 1999 Oct; 24(10):1203-7. PubMed ID: 10492514
[TBL] [Abstract][Full Text] [Related]
22. Delta receptor involvement in morphine suppression of noxiously evoked activity of spinal WDR neurons in cats.
Omote K; Kitahata LM; Nakatani K; Collins JG
Brain Res; 1991 Jul; 554(1-2):299-303. PubMed ID: 1657291
[TBL] [Abstract][Full Text] [Related]
23. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
Schoffelmeer AN; Hogenboom F; Mulder AH
Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
[TBL] [Abstract][Full Text] [Related]
24. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
25. Mu and delta opioid receptors inhibit serotonin release in rat hippocampus.
Passarelli F; Costa T
J Pharmacol Exp Ther; 1989 Jan; 248(1):299-305. PubMed ID: 2536429
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of calcium currents in rat colon sensory neurons by K- but not mu- or delta-opioids.
Su X; Wachtel RE; Gebhart GF
J Neurophysiol; 1998 Dec; 80(6):3112-9. PubMed ID: 9862909
[TBL] [Abstract][Full Text] [Related]
27. Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord.
Malcangio M; Bowery NG
Br J Pharmacol; 1994 Oct; 113(2):635-41. PubMed ID: 7530576
[TBL] [Abstract][Full Text] [Related]
28. Morphine produces release of substance P-like immunoreactivity from guinea-pig central nervous system.
Chahl LA
Neurosci Lett; 1990 Oct; 118(1):88-90. PubMed ID: 1701871
[TBL] [Abstract][Full Text] [Related]
29. Evidence for the interaction of morphine with kappa and delta opioid receptors to induce analgesia in beta-funaltrexamine-treated mice.
Takemori AE; Portoghese PS
J Pharmacol Exp Ther; 1987 Oct; 243(1):91-4. PubMed ID: 2822908
[TBL] [Abstract][Full Text] [Related]
30. Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine.
Hayes AG; Sheehan MJ; Tyers MB
Br J Pharmacol; 1985 Dec; 86(4):899-904. PubMed ID: 3000501
[TBL] [Abstract][Full Text] [Related]
31. Role of kappa opioid receptors in modulating cholinergic twitches in the circular muscle of guinea-pig colon.
Giuliani S; Lecci A; Tramontana M; Maggi CA
Br J Pharmacol; 1996 Nov; 119(5):985-9. PubMed ID: 8922749
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of μ-opioid receptor inhibition of NMDA receptor-induced substance P release in the rat spinal cord.
Chen W; Ennes HS; McRoberts JA; Marvizón JC
Neuropharmacology; 2018 Jan; 128():255-268. PubMed ID: 29042318
[TBL] [Abstract][Full Text] [Related]
33. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
[TBL] [Abstract][Full Text] [Related]
34. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
35. Effect of opioids on acetylcholine release evoked by K+ or glutamic acid from rat neostriatal slices.
Arenas E; Alberch J; Sanchez Arroyos R; Marsal J
Brain Res; 1990 Jul; 523(1):51-6. PubMed ID: 1976420
[TBL] [Abstract][Full Text] [Related]
36. Depression of C fibre-evoked spinal field potentials by the spinal delta opioid receptor is enhanced in the spinal nerve ligation model of neuropathic pain: involvement of the mu-subtype.
Buesa I; Urrutia A; Aira Z; Salgueiro M; Bilbao J; Mozas M; Aguilera L; Zimmermann M; Azkue JJ
Neuropharmacology; 2008 Dec; 55(8):1376-82. PubMed ID: 18775732
[TBL] [Abstract][Full Text] [Related]
37. Morphine preconditions Purkinje cells against cell death under in vitro simulated ischemia-reperfusion conditions.
Lim YJ; Zheng S; Zuo Z
Anesthesiology; 2004 Mar; 100(3):562-8. PubMed ID: 15108969
[TBL] [Abstract][Full Text] [Related]
38. Effects of prenatal morphine and adult estrogen administration on mu-opioid inhibition of norepinephrine release from hypothalamic slices.
Vathy I; Etgen AM
Neuroendocrinology; 1996 Jan; 63(1):61-8. PubMed ID: 8839356
[TBL] [Abstract][Full Text] [Related]
39. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
[TBL] [Abstract][Full Text] [Related]
40. Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats.
Takemori AE; Schwartz MM; Portoghese PS
J Pharmacol Exp Ther; 1988 Dec; 247(3):971-4. PubMed ID: 2849679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
